JP2024505212A - Ｃｂｄを用いた睡眠時無呼吸の処置 - Google Patents

Ｃｂｄを用いた睡眠時無呼吸の処置 Download PDF

Info

Publication number
JP2024505212A
JP2024505212A JP2023545813A JP2023545813A JP2024505212A JP 2024505212 A JP2024505212 A JP 2024505212A JP 2023545813 A JP2023545813 A JP 2023545813A JP 2023545813 A JP2023545813 A JP 2023545813A JP 2024505212 A JP2024505212 A JP 2024505212A
Authority
JP
Japan
Prior art keywords
cbd
sleep
patients
subject
dee
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023545813A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024505212A5 (https=
Inventor
パルーンボ，ジョーセフ
ガターマン，ドナ
セブリー，テリ
Original Assignee
ジナーバ・ファーマシューティカルズ・インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジナーバ・ファーマシューティカルズ・インコーポレイテッド filed Critical ジナーバ・ファーマシューティカルズ・インコーポレイテッド
Publication of JP2024505212A publication Critical patent/JP2024505212A/ja
Publication of JP2024505212A5 publication Critical patent/JP2024505212A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glass Compositions (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
JP2023545813A 2021-01-28 2022-01-28 Ｃｂｄを用いた睡眠時無呼吸の処置 Pending JP2024505212A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163142835P 2021-01-28 2021-01-28
US63/142,835 2021-01-28
PCT/IB2022/050781 WO2022162621A1 (en) 2021-01-28 2022-01-28 Treatment of sleep apnea with cbd

Publications (2)

Publication Number Publication Date
JP2024505212A true JP2024505212A (ja) 2024-02-05
JP2024505212A5 JP2024505212A5 (https=) 2025-01-28

Family

ID=80222209

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023545813A Pending JP2024505212A (ja) 2021-01-28 2022-01-28 Ｃｂｄを用いた睡眠時無呼吸の処置

Country Status (11)

Country Link
US (1) US20240307418A1 (https=)
EP (1) EP4284349A1 (https=)
JP (1) JP2024505212A (https=)
KR (1) KR20230137404A (https=)
CN (1) CN116829135A (https=)
AU (1) AU2022213009A1 (https=)
CA (1) CA3206508A1 (https=)
IL (1) IL304827A (https=)
JO (1) JOP20230169A1 (https=)
MX (1) MX2023008876A (https=)
WO (1) WO2022162621A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2627344A (en) * 2022-12-16 2024-08-21 Kingdom Therapeutics Ltd Cannabinoid based therapy

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019224824A1 (en) * 2018-05-24 2019-11-28 To Pharmaceuticals Llc Cannabis-based compositions for the treatment of autistic spectrum disorders
JP2020524151A (ja) * 2017-06-19 2020-08-13 ゼルダ セラピューティクス オペレーションズ ピーティーワイ リミテッド 睡眠障害組成物及びその治療

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8449908B2 (en) 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
CA2760460C (en) 2009-04-28 2019-04-02 Alltranz Inc. Transdermal formulations of cannabidiol comprising a penetration enhancer and methods of using the same
IL278548B2 (en) * 2018-05-11 2025-07-01 Rhodes Tech Inc Pharmaceutical preparations containing dronabinol and sprays containing the same pharmaceutical preparations
BR112022004175A2 (pt) * 2019-09-17 2022-05-31 Zynerba Pharmaceuticals Inc Tratamento de encefalopatia de syngap1

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020524151A (ja) * 2017-06-19 2020-08-13 ゼルダ セラピューティクス オペレーションズ ピーティーワイ リミテッド 睡眠障害組成物及びその治療
WO2019224824A1 (en) * 2018-05-24 2019-11-28 To Pharmaceuticals Llc Cannabis-based compositions for the treatment of autistic spectrum disorders

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
QUALITY OF LIFE AND SLEEP ASSESSMENTS IN CHILDREN WITH DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES, JPN5024009356, 4 December 2020 (2020-12-04), pages 1, ISSN: 0005723100 *
ZYNERBA PHARMACEUTICALS PRESENTS NEW DATA IN TWO POSTERS AT THE 2020 ANNUAL MEETING OF THE AMERICAN, JPN5024009357, 4 December 2020 (2020-12-04), pages 1 - 8, ISSN: 0005723101 *

Also Published As

Publication number Publication date
EP4284349A1 (en) 2023-12-06
MX2023008876A (es) 2023-09-12
CN116829135A (zh) 2023-09-29
KR20230137404A (ko) 2023-10-04
AU2022213009A1 (en) 2023-08-17
WO2022162621A1 (en) 2022-08-04
JOP20230169A1 (ar) 2023-07-27
IL304827A (en) 2023-09-01
CA3206508A1 (en) 2022-08-04
US20240307418A1 (en) 2024-09-19

Similar Documents

Publication Publication Date Title
Taranto-Montemurro et al. The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial
US12508270B2 (en) Treatment of behavioral impairment in developmental and epileptic encephalopathy
JP2023552390A (ja) 難治性発作の治療
US20250213465A1 (en) Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adults
Shahbazi et al. The effects of atomoxetine and trazodone combination on obstructive sleep apnea and sleep microstructure: A double-blind randomized clinical trial study
US20260076984A1 (en) Treatment of behavioral impairment in developmental and epileptic encephalopathy
Rahman et al. Lavender aromatherapy: Its effect on preoperative anxiety and propofol requirement for anesthesia
US20240307418A1 (en) Treatment of sleep apnea with cbd
Erman et al. The effect of armodafinil on patient-reported functioning and quality of life in patients with excessive sleepiness associated with shift work disorder: a randomized, double-blind, placebo-controlled trial
EP4507689A1 (en) Treatment of seizure disorders
CN116782891A (zh) 大麻二酚对难治性癫痫发作的治疗

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250120

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250120

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20251031

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251104

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260120